Failure of oral zinc supplementation in atopic eczema

C. I. Ewing, A. C C Gibbs, C. Ashcroft, T. J. David

    Research output: Contribution to journalArticlepeer-review


    An eight week double-blind placebo-controlled trial of oral zinc sulphate 185.4 mg per day was undertaken in 50 children with atopic eczema aged 1-16 years. In those receiving zinc there was no significant improvement in disease severity as assessed by surface area affected and degree of erythema, symptom scores of itch, sleep disturbance and redness of skin, or weight of emollient or topical steroid use.
    Original languageEnglish
    Pages (from-to)507-510
    Number of pages3
    JournalEuropean Journal of Clinical Nutrition
    Issue number10
    Publication statusPublished - 1991


    Dive into the research topics of 'Failure of oral zinc supplementation in atopic eczema'. Together they form a unique fingerprint.

    Cite this